| 000 | 01305 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250514000619.0 | ||
| 264 | 0 | _c20010906 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.45.6.1828-1835.2001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEspinel-Ingroff, A | |
| 245 | 0 | 0 |
_aOptimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cJun 2001 |
||
| 300 |
_a1828-35 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntifungal Agents _xpharmacology |
| 650 | 0 | 4 |
_aAspergillus _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aBartlett, M | |
| 700 | 1 | _aChaturvedi, V | |
| 700 | 1 | _aGhannoum, M | |
| 700 | 1 | _aHazen, K C | |
| 700 | 1 | _aPfaller, M A | |
| 700 | 1 | _aRinaldi, M | |
| 700 | 1 | _aWalsh, T J | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 45 _gno. 6 _gp. 1828-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.45.6.1828-1835.2001 _zAvailable from publisher's website |
| 999 |
_c11286039 _d11286039 |
||